EC Number |
Inhibitors |
Structure |
---|
3.2.1.182 | 2-(1-(4-(2-cyanophenyl)benzyl-1H-indol-3-yl),2,4-dihydro-1H-benzo(d)(1,3))oxazine |
slight inhibition |
|
3.2.1.182 | 2-(1H-indol-3-yl)-2,4-dihydro-1H-benzo[d][1,3]oxazine |
- |
|
3.2.1.182 | 2-(2-butyl-4-chloro-1H-imidazol-5-yl)-2,4-dihydro-1H-benzo[d][1,3]oxazine |
- |
|
3.2.1.182 | 2-(2-methyl-1H-indol-3-yl)-2,4-dihydro-1H-benzo[d][1,3]oxazine |
- |
|
3.2.1.182 | 2-fluoro-2-deoxy-beta-D-glucose |
- |
|
3.2.1.182 | 3-(2,4-dihydro-1H-benzo[d][1,3]oxazin-2-yl)-4H-chromen-4-one |
slight inhibition |
|
3.2.1.182 | 3-(6-chloro-2,4-dihydro-1H-benzo[d][1,3]oxazin-2-yl)-4H-chromen-4-one |
- |
|
3.2.1.182 | 3-(6-methyl-2,4-dihydro-1H-benzo[d][1,3]oxazin-2-yl)-4H-chromen-4-one |
slight inhibition |
|
3.2.1.182 | 4-(2,4-dihydro-1H-benzo[d][1,3]oxazin-2-yl)phenol |
- |
|
3.2.1.182 | 4-(7-chloro-2,4-dihydro-1H-benzo[d][1,3]oxazin-2-yl)phenol |
anti-hyperglycemic effect via glucose uptake inhibition by the inhibitor in the starved rat model |
|